Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Miller

Showing results (81-90 of 163) with videos related to

Pageof 17
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 24, 2012
Primary pineal tumors: outcome and prognostic factors--a study from the Rare Cancer Network (RCN)Salvador Villà, Robert C Miller, Marco Krengli, et al.
Digestive Diseases and Sciences|January 23, 2010
Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry studyRobert C Miller, Pamela J Atherton, Brian F Kabat, et al.
International Journal of Radiation Oncology, Biology, Physics|August 8, 2013
Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT)Brandon M Barney, Svetomir N Markovic, Nadia N Laack, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 2009
A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapyKiran Devisetty, Loren K Mell, Joseph K Salama, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 16, 2012
Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CAPamela J Atherton, Michele Y Halyard, Jeff A Sloan, et al.
Rare Tumors|February 23, 2012
Radiotherapy for marginally resected, unresectable or recurrent giant cell tumor of the bone: a rare cancer network studySumita Bhatia, Leszek Miszczyk, Martine Roelandts, et al.
The Journal of Physical Chemistry. B|April 9, 2020
FRET Analysis of Ionic Strength Sensors in the Hofmeister Series of Salt Solutions Using Fluorescence Lifetime MeasurementsRobert C Miller, Cody P Aplin, Taryn M Kay, et al.
The American Journal of the Medical Sciences|December 19, 2008
Small cell (neuroendocrine) carcinoma of the prostate: etiology, diagnosis, prognosis, and therapeutic implications--a retrospective study of 30 patients from the rare cancer networkMoshe E Stein, Zvi Bernstein, Ufuc Abacioglu, et al.
Journal of Radiosurgery and SBRT|January 4, 2018
Lung stereotactic body radiotherapy using a coplanar versus a non-coplanar beam technique: a comparison of clinical outcomesChristopher L Hallemeier, Michael C Stauder, Robert C Miller, et al.
Radiation Oncology (London, England)|April 19, 2015
Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodulesDawn Owen, Kenneth R Olivier, Charles S Mayo, et al.
Pageof 17

Showing results (81-90 of 163) with videos related to

Sort By:
Pageof 17
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 24, 2012
Primary pineal tumors: outcome and prognostic factors--a study from the Rare Cancer Network (RCN)Salvador Villà, Robert C Miller, Marco Krengli, et al.
Digestive Diseases and Sciences|January 23, 2010
Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry studyRobert C Miller, Pamela J Atherton, Brian F Kabat, et al.
International Journal of Radiation Oncology, Biology, Physics|August 8, 2013
Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT)Brandon M Barney, Svetomir N Markovic, Nadia N Laack, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 2009
A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapyKiran Devisetty, Loren K Mell, Joseph K Salama, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 16, 2012
Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CAPamela J Atherton, Michele Y Halyard, Jeff A Sloan, et al.
Rare Tumors|February 23, 2012
Radiotherapy for marginally resected, unresectable or recurrent giant cell tumor of the bone: a rare cancer network studySumita Bhatia, Leszek Miszczyk, Martine Roelandts, et al.
The Journal of Physical Chemistry. B|April 9, 2020
FRET Analysis of Ionic Strength Sensors in the Hofmeister Series of Salt Solutions Using Fluorescence Lifetime MeasurementsRobert C Miller, Cody P Aplin, Taryn M Kay, et al.
The American Journal of the Medical Sciences|December 19, 2008
Small cell (neuroendocrine) carcinoma of the prostate: etiology, diagnosis, prognosis, and therapeutic implications--a retrospective study of 30 patients from the rare cancer networkMoshe E Stein, Zvi Bernstein, Ufuc Abacioglu, et al.
Journal of Radiosurgery and SBRT|January 4, 2018
Lung stereotactic body radiotherapy using a coplanar versus a non-coplanar beam technique: a comparison of clinical outcomesChristopher L Hallemeier, Michael C Stauder, Robert C Miller, et al.
Radiation Oncology (London, England)|April 19, 2015
Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodulesDawn Owen, Kenneth R Olivier, Charles S Mayo, et al.
Pageof 17